JB Chemicals cetirizine tablets recalled for ranitidine contamination
Customers reported discolored cetirizine tablets with red dots. The agency determined the red dots to be ranitidine, which is a cross-contamination from other products. The recall covers Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottles, made by Unique Pharmaceuticals Labs and distributed by Rising Pharma Holdings.
From the FDA notice · Read the official notice ↗
What to do
- Stop taking tablets from the affected lots.
- Check the bottle for NDC 16571-401-10 and lot GY825029, GY825030, GY825031 or GY825032, with expiration 2028-OCT.
- The notice doesn't say how to get a refund or replacement; contact Rising Pharma Holdings or where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 34,020 100-count bottles.
- Illnesses reported
- None reported
- Manufactured in
- Neelam Centre A Wing A B Wing, 4th Floor; Hind Cycle Road, Mumbai, N/A, India
- Classification
- Class I
- Recall number
- D-0732-2026
In the FDA's words
- Description
- Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10. Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine. Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT Distribution: Nationwide in the USA Affected quantity: 34,020 100-count bottles.
- Hazard
- Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.